Fidelta’s bioanalytical team provides a range of non-GLP quantitative analytical support of discovery phase studies, as well as biomarker measurements and GLP bioanalysis including method development and transfer, method validation and sample analysis in compliance with internal SOPs and in-line with regulatory bioanalytical guidelines and white papers.
Rapid turnaround is ensured through efficient sample preparation, state-of-the art LC-MS/MS systems and a dedicated instrument maintenance team.
Extensive bioanalytical experience and knowledge of drug metabolism, in combination with advanced software and instruments, enables high quality metabolite identification and profiling in in vitro and in vivo systems.
- Qualitative and quantitative non-GLP bioanalysis using state-of-the-art LC-MS/MS equipment
- GLP compliant bioanaysis
- Method development
- Method transfer
- Method validation
- Sample analysis
- Biomarker analysis